[Pharmacokinetic studies of quercetin-hydroxypropyl-beta-cyclodextrin inclusion compound in rats]

Zhong Yao Cai. 2005 Jan;28(1):47-50.
[Article in Chinese]

Abstract

To estabilish a HPLC method for determination of quercetin-hydroxypropyl-beta-cyclodextrin in rats plasma and investigate the pharmacokinetics characteristics of it in rats. The plasma was extracted with methanol-aceitc acid (9:1). The mobile phase was acetonitrilewater. Absorbance of the effluence was monitored at 360 nm. The linear limit of quercetin was within the range of 1 to 150 microg/ml. The lowest limit of quercetin was 0.5 microg/ml. The concentration-time curve of quercetin in rats was considered of a two-compartment open model, and the t1/2 (beta) of the inclusion compound when ig is 2.220 h, the t1/2 (beta) of the inclusion compound when iv is 90.871 min.

MeSH terms

  • 2-Hydroxypropyl-beta-cyclodextrin
  • Animals
  • Biological Availability
  • Chromatography, High Pressure Liquid / methods
  • Drug Carriers
  • Drugs, Chinese Herbal / chemistry
  • Drugs, Chinese Herbal / pharmacokinetics*
  • Male
  • Plants, Medicinal / chemistry*
  • Quercetin / blood
  • Quercetin / pharmacokinetics*
  • Rats
  • beta-Cyclodextrins / blood
  • beta-Cyclodextrins / pharmacokinetics*

Substances

  • Drug Carriers
  • Drugs, Chinese Herbal
  • beta-Cyclodextrins
  • 2-Hydroxypropyl-beta-cyclodextrin
  • Quercetin